Cypress Capital Management LLC WY acquired a new stake in IntriCon Co. (NASDAQ:IIN) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,590 shares of the technology company’s stock, valued at approximately $314,000. Cypress Capital Management LLC WY owned approximately 0.06% of IntriCon at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in IIN. Acadian Asset Management LLC grew its stake in IntriCon by 3.1% in the third quarter. Acadian Asset Management LLC now owns 56,179 shares of the technology company’s stock valued at $3,157,000 after purchasing an additional 1,715 shares during the last quarter. Columbus Circle Investors purchased a new position in IntriCon in the third quarter valued at about $2,829,000. Russell Investments Group Ltd. purchased a new position in IntriCon in the third quarter valued at about $348,000. CAPROCK Group Inc. purchased a new position in IntriCon in the third quarter valued at about $251,000. Finally, Northern Trust Corp grew its stake in IntriCon by 257.6% in the second quarter. Northern Trust Corp now owns 90,616 shares of the technology company’s stock valued at $3,651,000 after purchasing an additional 65,276 shares during the last quarter. Hedge funds and other institutional investors own 42.25% of the company’s stock.
In other news, Director Philip Irving Smith sold 10,000 shares of the business’s stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $74.18, for a total transaction of $741,800.00. Following the sale, the director now owns 6,667 shares in the company, valued at $494,558.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 21.20% of the stock is currently owned by insiders.
Shares of IIN stock opened at $41.88 on Thursday. IntriCon Co. has a fifty-two week low of $11.00 and a fifty-two week high of $76.80. The stock has a market cap of $374.06 million, a PE ratio of 144.41, a price-to-earnings-growth ratio of 4.97 and a beta of 0.57. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.85 and a current ratio of 1.56.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Story: What is a conference call?
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.